Temporomandibular Joint and COVID-19 (NCT05077189) | Clinical Trial Compass
CompletedNot Applicable
Temporomandibular Joint and COVID-19
Turkey (Türkiye)76 participantsStarted 2020-12-01
Plain-language summary
There is evidence that CV-19 is associated with joint symptoms, but there are no specific data on the temporomandibular joint (TMJ). It is also known that the systemic health status can impact the immune system. Given all this, this study aimed to investigate the effect of CV-19 and systemic health status, as determined by the American Society of Anesthesiologists (ASA) Physical Status Classification System 12, on TMJ in patients with TMJ complaints using the DC/TMD scale.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* applied to our clinic with TMJ discomfort
* ASA 1 and ASA 2 patients
Exclusion Criteria:
* patients with acute CV-19
* Patients who are not in ASA 1 or ASA 2 classification
* Patients under 18 year-old
* Pregnants
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
DC/TMD scale - Demographics Survey
Timeframe: through study completion an average of 3 months
2
DC/TMD scale - DC/TMD Symptom Questionnaire
Timeframe: through study completion an average of 3 months
3
DC/TMD scale - Graded Chronic Pain Scale
Timeframe: through study completion an average of 3 months
4
DC/TMD scale - Jaw Functional Limitation Scale-20
Timeframe: through study completion an average of 3 months
Trial details
NCT IDNCT05077189
SponsorRecep Tayyip Erdogan University Training and Research Hospital